Array BioPharma Reports Initial Results From Novel Immunotherapy Combination At The Society For Immunotherapy … – PR Newswire (press release)
|
Array BioPharma Reports Initial Results From Novel Immunotherapy Combination At The Society For Immunotherapy …
PR Newswire (press release) BOULDER, Colo., Nov. 13, 2017 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule cancer therapies, today announced data from … |
